Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769558 · ClinicalTrials.gov registry record
A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 264
- Enrollment target
NCT03769558 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 264 participants.
The verdict
NCT03769558 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 264 participants
- Enrollment target
Study Summary
This study will determine the incidences of infections and malignancies among JIA patients treated with abatacept
Interventions
- OTHER Non-Interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2016-07-12 |
| Est. Completion | 2016-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03769558
The ClinicalTrials.gov registry entry for NCT03769558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional is the first listed.
NCT03769558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03769558 about?
NCT03769558 is a clinical study titled "A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur". This study will determine the incidences of infections and malignancies among JIA patients treated with abatacept
What is the current status of trial NCT03769558?
This trial is currently completed. The enrollment target is 264 participants. The study started on 2016-07-12. Estimated completion is 2016-09-30.
What interventions are being tested in trial NCT03769558?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT03769558?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.